Generic immunosuppressants have reduced costs after organ transplantation
The introduction of generic versions of immunosuppressive drugs has resulted in substantial cost savings for transplant patients and Medicare, according to a study appearing in an upcoming issue of the Clinical Journal of ...
Feb 28, 2019